Finance
Biopharma company announces third quarter 2003 financial results
Published in Medical Letter on the CDC and FDA, December 7th, 2003
GenVec reported higher revenues and a lower net loss through the first 9 months of 2003 compared with the same 9-month period last year. For the 9 months ended September 30, 2003, the company reported a net loss of $16.0 million or $0.60 per share on revenues of $8.1 million compared to a net loss of $20.2 million or $0.93 per share on revenues of $4.9 million for the comparable 9-month period in 2002. GenVec reported a net loss of $4.9 million or $0.14 per share in the current quarter ended September 30, 2003, compared to a net loss of $6.9...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Food-borne Illness
Filtration membrane applied to IR spectroscopic discrimination of bacteria - Mosquito-borne Disease
Genomics spawns novel approaches to mosquito control - Breast Cancer Screening
Cancer registry useful for Florida breast cancer early detection program - Cardiology
Model for computing motion of mechanical heart-valve leaflets developed - Giardiasis
Oral immunization with Giardia duodenalis protein inhibits shedding of cysts - Streptococcus Vaccine
CDCP recommends pneumococcal polysaccharide vaccine for adults older than 65 - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
